Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?

The International journal of biological markers - 17 Dec 2013

Gaibar María, Fernández Gerónimo, Romero-Lorca Alicia, Novillo Apolonia, Tejerina Armando, Bandrés Fernando, Fernández-Santander Ana

Abstract excerpt

OBJECTIVE: This study examines the lipid profile change produced in response to tamoxifen (TAM) treatment, and its possible relationship with both apolipoprotein E genotype and menopausal state in patients with breast cancer. METHODS: Blood samples were collected from 86 Spanish women with breast cancer before initiating TAM treatment and in the following 6, 12 and 18 months of treatment. Plasma lipid levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Lipid Metabolism

Share to Lipids

Share to Postmenopause

Share to Tamoxifen

Share to Triglycerides

Source

Identifiers

PMID: 23828408
DOI: 10.5301/jbm.5000037

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?PMID 23828408Read ↗

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Semantic proximity Read ↗

Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.Semantic proximity Read ↗

Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.Semantic proximity Read ↗

The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.Semantic proximity Read ↗

Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.Semantic proximity Read ↗

Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.Semantic proximity Read ↗

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?Semantic proximity Read ↗

Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use.Semantic proximity Read ↗

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.Semantic proximity Read ↗

Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene.Semantic proximity Read ↗

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.Semantic proximity Read ↗

HER2 codon 655 G-allele is associated with reductions in plasma high-density lipoprotein levels in breast cancer patients treated with tamoxifen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.